1. Home
  2. IGC vs WKSP Comparison

IGC vs WKSP Comparison

Compare IGC & WKSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IGC
  • WKSP
  • Stock Information
  • Founded
  • IGC 2005
  • WKSP 2003
  • Country
  • IGC United States
  • WKSP United States
  • Employees
  • IGC N/A
  • WKSP N/A
  • Industry
  • IGC Biotechnology: Pharmaceutical Preparations
  • WKSP Auto Parts:O.E.M.
  • Sector
  • IGC Health Care
  • WKSP Consumer Discretionary
  • Exchange
  • IGC Nasdaq
  • WKSP Nasdaq
  • Market Cap
  • IGC 20.2M
  • WKSP 14.6M
  • IPO Year
  • IGC N/A
  • WKSP N/A
  • Fundamental
  • Price
  • IGC $0.34
  • WKSP $4.00
  • Analyst Decision
  • IGC Strong Buy
  • WKSP Strong Buy
  • Analyst Count
  • IGC 2
  • WKSP 3
  • Target Price
  • IGC $3.88
  • WKSP $12.83
  • AVG Volume (30 Days)
  • IGC 7.0M
  • WKSP 272.7K
  • Earning Date
  • IGC 08-07-2025
  • WKSP 08-12-2025
  • Dividend Yield
  • IGC N/A
  • WKSP N/A
  • EPS Growth
  • IGC N/A
  • WKSP N/A
  • EPS
  • IGC N/A
  • WKSP N/A
  • Revenue
  • IGC $1,271,000.00
  • WKSP $10,211,747.00
  • Revenue This Year
  • IGC $15.26
  • WKSP $159.92
  • Revenue Next Year
  • IGC $3.41
  • WKSP $68.25
  • P/E Ratio
  • IGC N/A
  • WKSP N/A
  • Revenue Growth
  • IGC N/A
  • WKSP 407.96
  • 52 Week Low
  • IGC $0.25
  • WKSP $2.44
  • 52 Week High
  • IGC $0.50
  • WKSP $12.00
  • Technical
  • Relative Strength Index (RSI)
  • IGC 52.76
  • WKSP 64.10
  • Support Level
  • IGC $0.30
  • WKSP $3.46
  • Resistance Level
  • IGC $0.46
  • WKSP $4.90
  • Average True Range (ATR)
  • IGC 0.03
  • WKSP 0.49
  • MACD
  • IGC 0.01
  • WKSP 0.10
  • Stochastic Oscillator
  • IGC 24.56
  • WKSP 73.04

About IGC IGC Pharma Inc.

IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.

About WKSP Worksport Ltd.

Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.

Share on Social Networks: